Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire12/21 06:00

After a Year of 0.6% Returns, Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Share Price Drop Last Week May Have Less of an Impact on Institutional Investors

Simply Wall St12/15 22:31

Peering Into Iovance Biotherapeutics's Recent Short Interest

Benzinga12/06 01:45

Is Iovance Biotherapeutics Stock a Millionaire Maker?

Yahoo Finance11/27 19:30

Press Release: Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Dow Jones11/27 05:01

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Iovance Biotherapeutics11/26 13:00